A newly awarded $4.1 million research grant from the National Institutes of Health (NIH) is set to improve how children with asthma receive care at school. Led by Dr. Marina Reznik of Montefiore Medical Center and Albert Einstein College of Medicine, the study aims to streamline communication among caregivers, clinicians, and schools — making it easier for students to access the medications they need, when they need them.
Collaborative Solutions for Better Asthma Management in Schools
Children with asthma may face barriers to receiving their prescribed medications at school. The current New York City (NYC) school system requires multiple steps and paper forms — creating gaps that delay treatment. Less than one-third of NYC students have all the necessary documentation in place, leaving many without access to critical asthma maintenance or rescue therapy during the school day.
Through the new NIH-funded project, titled Promoting Asthma Guidelines and Management through Technology-Based Intervention and Care Coordination in Clinics and Schools (PRAGMATIC-S), Dr. Reznik and her team will create an electronic system allowing caregivers, clinicians, and schools to complete and share medication authorization forms online. Families participating in the study will also receive support from Asthma Outreach Workers who help navigate care barriers, ensure access to medication, and educate families on proper inhaler use.
A Shared Commitment to Accessible, Effective Asthma Care
At Monaghan Medical, we share this commitment to removing barriers to asthma management. Consistent, guideline-based care depends not only on coordination but also on the effective delivery of prescribed medications — a challenge Monaghan’s devices are specifically designed to address.
Products like the AeroChamber® Plus Flow-Vu® Valved Holding Chamber and the AeroEclipse® II BAN® Nebulizer help ensure medication reaches the lungs efficiently, improving symptom control and supporting adherence in both clinical and school settings. For children using inhalers at school, devices that simplify correct medication use can make a measurable difference in health outcomes, attendance, and quality of life.
Evidence-Based Solutions for Pediatric Asthma
Research-driven partnerships, such as this NIH-backed Montefiore study, underscore how technology and evidence-based tools can work together to close gaps in pediatric asthma care. We’re proud that Monaghan Medical products are routinely used in similar clinical studies worldwide — contributing to improved medication delivery standards and advancing the management of children’s care..
As the PRAGMATIC-S study progresses, its findings may provide valuable insights into how coordinated systems and proven medication delivery devices can jointly support better asthma control — both in the classroom and beyond.
For more information about Monaghan Medical’s commitment to improving outcomes for children with asthma, visit our Asthma Treatment Overview or explore our AeroChamber Plus® Flow-Vu® and AeroEclipse® II BAN® Nebulizer product pages.
*Photo credit: PRNewswire.com
